Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Minoryx Therapeutics
Biotech
Minoryx pockets €51M to guide rare disease drug to market
Minoryx has persuaded investors to overlook its phase 2/3 failure, and it pulled in 51 million euros to support a push to bring the drug to market.
Nick Paul Taylor
May 31, 2022 10:00am
Roche-backed Minoryx raises €21M to expand CNS R&D
Sep 26, 2018 8:50am
EuroBiotech: More Articles of Note
Feb 22, 2018 10:00am
Novartis, Sanofi-backed NeuroVia closes $14M series A
Jul 20, 2017 7:30am